Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.2 EUR | +1.15% | +1.15% | -56.15% |
22/05 | Transcript : Marinomed Biotech AG, Q1 2024 Earnings Call, May 22, 2024 | |
21/05 | Marinomed Biotech AG Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Business Summary
Sales per Business
EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Virology
99.3
%
| 11 | 99.3 % | 9 | 99.3 % | -18.60% |
Other
0.7
%
| 0 | 0.7 % | 0 | 0.7 % | -12.87% |
Sales per region
EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Other European Countries
50.9
%
| 7 | 60.8 % | 5 | 50.9 % | -31.82% |
Non-European Countries
43.3
%
| 3 | 30.4 % | 4 | 43.3 % | +15.73% |
Austria
5.8
%
| 1 | 8.8 % | 1 | 5.8 % | -45.68% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 55 | 01/06/01 | |
Founder | 56 | 01/06/01 | |
Pascal Schmidt
DFI | Director of Finance/CFO | 52 | 01/18/01 |
Chief Operating Officer | - | 01/11/01 | |
Renate Moser
PRN | Corporate Officer/Principal | - | 01/15/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 58 | 01/08/01 | |
Brigitte Ederer
BRD | Director/Board Member | 68 | 21/18/21 |
Director/Board Member | - | 15/22/15 | |
Ulrich Kinzel
BRD | Director/Board Member | 60 | 15/22/15 |
Director/Board Member | - | 20/23/20 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,540,530 | 1,002,892 ( 65.10 %) | 0 | 65.10 % |
Company contact information
Sector
Sales per Business
Sales per region
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+0.85% | 92.38B | |
-3.03% | 37.9B | |
-10.46% | 33.73B | |
+74.71% | 27.98B | |
-13.39% | 15.86B | |
-1.08% | 13.97B | |
-11.15% | 11.67B | |
+169.04% | 10.17B | |
-50.19% | 10.04B |
- Stock Market
- Equities
- MARI Stock
- 93Z Stock
- Company Marinomed Biotech AG